Clinical trial · Interventional
Double Bypass Versus Stent-treatment in Irresectable Pancreatic Cancer
Double Bypass vs Stent Strategy in Peroperatively Diagnosed Irresectable Pancreatic Cancer - A Prospective Randomized Multicenter Study
NCT01569282CI-TRIAL-00037755withdrawnN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Difficulties to recruit patients
Summary
Brief summary (as posted)
Double bypass (hepaticojejunostomy + gastrojejunostomy) is compared to stent strategy in patients planned for curative pancreatic resection in whom peroperative findings makes resection impossible.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Pancreatic Cancer | Malignant Pancreatic Neoplasm | CURATED_EXACT | 0.92 |
| Periampullary Tumor | Pancreatic Neoplasm | PROBABILISTIC | 0.70 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Hepaticojejunostomy and gastroenterostomy | Procedure | — | UNRESOLVED |
| Stent strategy | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- Double bypass
- interventionNames
- Procedure: Hepaticojejunostomy and gastroenterostomy
- type
- ACTIVE_COMPARATOR
- label
- Stent Strategy
- interventionNames
- Procedure: Stent strategy
Primary outcomes (1)
- measure
- Morbidity
- timeFrame
- Day 1-30 after randomization
- description
- Initial morbidity in association to the laparotomy using the Clavien-Dindo Classification.
Secondary outcomes (3)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 85 Years
Show eligibility criteria text
Inclusion Criteria: 1. Preoperatively * Patients with stent treated tumor in the pancreatic head or periampullary planned for pancreaticoduodenectomy * The patient jaundice should have worn off and there should be no signs of duodenal obstruction * The patient has given informed consent after verbal and written information in accordance with approved ethics application * The patient has no anatomical conditions making endoscopic therapy impossible such as previous Billroth II or Gastric Bypass. 2. Intraoperatively * Peroperative findings of of carcinomatosis, metastases or local irresectability who oppose radical surgery * Surgical double bypass should be technically feasible * The patient has given informed consent after verbal and written information in accordance with approved ethics application Exclusion Criteria: * Peroperative signs of dysfunction on biliary stent * Peroperative findings of gastric outlet obstruction * Surgical double bypass not technically feasible
References
Publications (0)
Data not yet available
No reference posted for this study.